随机试验的元分析
Alonzo Armani Prata1, Ana Carolina Covre Coan1, Megan Coylewright2
1Federal University of Espírito Santo, Vitória, Brazil.
Current problems in cardiology
|August 22, 2025
概括
在心力衰竭中使用心脏间的分离疗法 (HFpEF) 显示了心力衰竭事件增加和心血管死亡的趋势. 在这种HFpEF治疗中,更好地选择患者至关重要.
科学领域:
- 心脏病学
- 干预心脏病学
- 心脏衰竭的研究
背景情况:
- 观察数据表明,通过解压左心室,心脏衰竭与保存的喷射分数 (HFpEF) 可能有所益处.
- 然而,可能受益于此干预的特定患者群体仍未确定.
研究的目的:
- 通过对随机对照试验 (RCT) 的分析,评估心脏间的临床疗效和安全性.
主要方法:
- 在HFpEF患者中系统地搜索RCT,比较心房间间间的分流与虚假手术.
- 主要结局包括心力衰竭事件和心血管死亡率.
主要成果:
- 分析了3项涉及966名患者的RCT,其中479名患者接受了心房间间的分流.
- 与虚假手术相比,心房间间间的分流疗法显示心力衰竭事件 (RR: 1.29) 和心血管死亡 (RR: 2. 30) 的风险增加.
- 在主要心血管不良事件 (MACE),生活质量,心肌梗塞或中风/ 暂时性缺血性发作率方面没有显著改善.
结论:
- 在HFpEF患者中,心房间间的分流治疗显示了心力衰竭事件和心血管死亡率较高的趋势,但没有显著的临床益处.
- 这些发现表明,在更广泛的HFpEF群体中广泛使用心房间间的分离器是需要谨慎的.
- 改善患者选择策略对于潜在的未来用于HFpEF的关治疗至关重要.
更多相关视频
06:10Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
3.4K
09:23Shunt Surgery, Right Heart Catheterization, and Vascular Morphometry in a Rat Model for Flow-induced Pulmonary Arterial Hypertension
Published on: February 11, 2017
16.9K
相关概念视频
Heart Failure V: Medical Management
23
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
23
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
505
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
505
Mitral Regurgitation III: Medical Management
30
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
30
